Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 5, 2013
A novel approach to improve the function of FGF21Richard Smith, Amy Duguay, Jennifer Weiszmann, et al.The Journal of Biological Chemistry|December 19, 2009
FGF19-induced hepatocyte proliferation is mediated through FGFR4 activationXinle Wu, Hongfei Ge, Bryan Lemon, et al.Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)Xinle Wu, Hongfei Ge, Bryan Lemon, et al.Scientific Reports|July 25, 2018
A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signalingSally Yu Shi, Ya-Wen Lu, Jason Richardson, et al.Journal of Lipid Research|December 4, 2012
Dual actions of fibroblast growth factor 19 on lipid metabolismXinle Wu, Hongfei Ge, Hélène Baribault, et al.Journal of Molecular Biology|February 29, 2012
A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlothoXinle Wu, Jennifer Weiszmann, Hongfei Ge, et al.The Journal of Biological Chemistry|October 3, 2008
C-terminal tail of FGF19 determines its specificity toward Klotho co-receptorsXinle Wu, Bryan Lemon, XiaoFan Li, et al.The Journal of Biological Chemistry|March 6, 2002
T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activitiesGary Lee, Fabienne Elwood, John McNally, et al.Plos One|March 30, 2012
Characterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolismHongfei Ge, Helene Baribault, Steven Vonderfecht, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulatorsYingcai Wang, Xianyun Jiao, Frank Kayser, et al.Pageof 3